UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience

Annals of surgical oncology, 2013-09, Vol.20 (9), p.2937-2943

2013

Volltextzugriff (PDF)

A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

Therapeutic advances in medical oncology, 2021, Vol.13, p.1758835921996506

2021

Volltextzugriff (PDF)

Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients

Journal of cancer research and clinical oncology, 2016-04, Vol.142 (4), p.795-805

2016

Volltextzugriff (PDF)

Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age

International journal of oncology, 2013-07, Vol.43 (1), p.23-28

2013

Volltextzugriff (PDF)

Arrhythmias in oncological patients: a compact overview for the clinician

Herzschrittmachertherapie & Elektrophysiologie, 2024-09, Vol.35 (3), p.177-182

2024

Volltextzugriff (PDF)

Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma

Future oncology (London, England), 2021-10, Vol.17 (30), p.3965-3976

2021

Volltextzugriff (PDF)

Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours

European urology, 2010-04, Vol.57 (4), p.679-687

2010

Volltextzugriff (PDF)

Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed

Journal of thoracic oncology, 2013-01, Vol.8 (1), p.19-30

2013

Volltextzugriff (PDF)

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial

Cancers, 2022-10, Vol.14 (21), p.5234

2022

Volltextzugriff (PDF)

A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS)

Lung cancer (Amsterdam, Netherlands), 2016-09, Vol.99, p.94-101

2016

Volltextzugriff (PDF)

Brain metastases in sarcoma patients: Incidence and outcome

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.10591-10591

2014

Volltextzugriff (PDF)

Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging

Clinical imaging, 2016-09, Vol.40 (5), p.956-960

2016

Volltextzugriff (PDF)

Malignant pleural mesothelioma: initial experience in integrated18F-FDG PET/MR imaging

Clinical imaging, 2016-09, Vol.40 (5), p.956

2016

Volltextzugriff (PDF)

Rechallenge with ifosfamide-containing regimen as salvage option for patients with metastatic soft tissue sarcomas progressing after multiple pretreatments

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10046-10046

2012

Volltextzugriff (PDF)

Correlation of proteomics and first-line platinum-based chemotherapy in stage III/IV NSCLC in a large single-center cohort

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19104-e19104

2014

Volltextzugriff (PDF)

Efficacy and safety results from CurrentS, a double-blind, randomized, phase III study of second-line erlotinib (150 mg versus 300 mg) in current smokers with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8046-8046

2014

Volltextzugriff (PDF)

Intimal sarcoma of the pulmonary artery with unusual findings: a case report

Clinical research in cardiology, 2012-05, Vol.101 (5), p.397-401

2012

Volltextzugriff (PDF)

Malignant pleural mesothelioma: Initial experience in integrated 18F-FDG PET/MR imaging

Clinical imaging, 2016-09, Vol.40 (5), p.956-960

2016

Volltextzugriff (PDF)

Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10032-10032

2012

Volltextzugriff (PDF)

Intimal sarcoma of the pulmonary artery with unusual findings: a case report

Clinical research in cardiology : official journal of the German Cardiac Society, 2012, Vol.101 (5), p.397-401

2012

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)
Berichte
(1)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience

A randomized, multicenter phase II study comparing efficacy, safety and tolerability of two dosing regimens of cisplatin and pemetrexed in patients with advanced or metastatic non-small-cell lung cancer

Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients

Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age

Arrhythmias in oncological patients: a compact overview for the clinician

Real-world efficacy of docetaxel plus nintedanib after chemo-immunotherapy failure in advanced pulmonary adenocarcinoma

Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours

Significance of Folate Receptor Alpha and Thymidylate Synthase Protein Expression in Patients with Non–Small-Cell Lung Cancer Treated with Pemetrexed

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial

A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS)

Brain metastases in sarcoma patients: Incidence and outcome

Malignant pleural mesothelioma: initial experience in integrated (18)F-FDG PET/MR imaging

Malignant pleural mesothelioma: initial experience in integrated18F-FDG PET/MR imaging

Rechallenge with ifosfamide-containing regimen as salvage option for patients with metastatic soft tissue sarcomas progressing after multiple pretreatments

Correlation of proteomics and first-line platinum-based chemotherapy in stage III/IV NSCLC in a large single-center cohort

Efficacy and safety results from CurrentS, a double-blind, randomized, phase III study of second-line erlotinib (150 mg versus 300 mg) in current smokers with advanced non-small cell lung cancer (NSCLC)

Intimal sarcoma of the pulmonary artery with unusual findings: a case report

Malignant pleural mesothelioma: Initial experience in integrated 18F-FDG PET/MR imaging

Phase I trial of panobinostat (P) and imatinib (IM) in patients with treatment-refractory gastrointestinal stromal tumors (GIST)

Intimal sarcoma of the pulmonary artery with unusual findings: a case report

Suchergebnisse filtern